INS and Glucose intolerance: Gefitinib treatment, even when combined with a high-fat diet, reduced the fasting insulin concentration, HOMA IR index and glucose intolerance to the levels seen in the standard diet group, indicating that gefitinib potentially improves insulin resistance in diabetic condition with dysregulated EGFR signaling.